Cargando…
Disrupting Ovarian Cancer Metastatic Colonization: Insights from Metastasis Suppressor Studies
Ovarian cancer affects approximately 25,000 women in the United States each year and remains one of the most lethal female malignancies. A standard approach to therapy is surgical cytoreduction, after which the remaining microscopic residual disease is treated with chemotherapy. The vast majority of...
Autores principales: | Khan, Shaheena, Taylor, Jennifer L., Rinker-Schaeffer, Carrie W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838371/ https://www.ncbi.nlm.nih.gov/pubmed/20300552 http://dx.doi.org/10.1155/2010/286925 |
Ejemplares similares
-
Molecular biology of breast cancer metastasis: Genetic regulation of human breast carcinoma metastasis
por: Welch, Danny R, et al.
Publicado: (2000) -
From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis
por: Thobe, Megan N., et al.
Publicado: (2011) -
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts
por: Fish, Lisa, et al.
Publicado: (2016) -
Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1
por: Krishnan, Venkatesh, et al.
Publicado: (2020) -
Metastasis of Ovarian Cancer to the Descending Colon
por: Abe, Kentaro, et al.
Publicado: (2023)